Hensoldt H1 2025 slides: Revenue up 14%, record €7.1B backlog amid margin pressure

Hensoldt AG reported strong H1 2025 revenue growth of 14% to €944 million and a record €7.07 billion order backlog, positioning it to capitalize on projected significant increases in German defense spending. Despite this top-line strength, the company experienced notable profitability pressure, with Adjusted EBITDA margin declining to 11.3% and free cash flow worsening to -€181 million, resulting in a larger net loss. However, Hensoldt reaffirmed its full-year 2025 guidance, including an ambitious 18% Adjusted EBITDA margin, implying a substantial recovery is expected in the second half, supported by strategic operational improvements and a robust order pipeline.

Analysis

Hensoldt AG (ETR:HAG) presented a dichotomous H1 2025 report, characterized by strong top-line growth and future revenue visibility contrasted with significant near-term profitability and cash flow pressures. The company reported a 14% core revenue increase to €944 million and expanded its order backlog to a record €7,070 million, supported by a robust 1.5x book-to-bill ratio. This performance is underpinned by powerful secular tailwinds, most notably the projected doubling of German defense spending by 2029, which positions Hensoldt favorably for major procurement programs. However, this growth came at a cost to margins, with the adjusted EBITDA margin contracting to 11.3% from 12.2% a year prior, and free cash flow worsening to -€181 million. The net loss also widened to €44 million. Despite these headwinds, management reaffirmed its ambitious full-year 2025 guidance, which includes an adjusted EBITDA margin of approximately 18%. This implies a substantial and rapid improvement in profitability is required in the second half of the year, placing significant emphasis on the successful execution of its 'Operations 2.0' efficiency program and other strategic initiatives.

Key Decisions for Investors

• Investors with a long-term horizon may see the current margin weakness as a temporary cost of scaling, focusing instead on the record €7.07 billion backlog and the company's prime position to capture increased European defense spending.
• It is critical to monitor the company's operational execution closely in H2 2025, as failure to deliver a significant margin recovery from 11.3% toward the 18% full-year target could pressure the stock's high valuation.
• Consider the reaffirmed full-year guidance as a high-conviction statement from management; however, the negative free cash flow of -€181 million represents a key risk factor that warrants scrutiny in subsequent reports before increasing exposure.